Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.75348 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.74718 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7222 | 32 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71974 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.69992 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.77134 | 31 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.74254 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.85304 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.72784 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.74395 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.74197 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.68898 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.7425 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.71275 | 32 |